Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs; Prohibiting drug manufacturers from engaging in certain acts relating to the acquisition of 340B drugs by and the delivery of such drugs to specified pharmacies; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of such insurers and health maintenance organizations, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs, etc.
Introduced
Jan 22, 2026
Last Action
Jan 22, 2026
Session
FL 2026
Sponsors
1 primary · 0 co
Introduced
Referred to Banking and Insurance; Health Policy; Rules
Filed
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Introduced